A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia

NCT07225712 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Otsuka Pharmaceutical Co., Ltd.